Seminars in Hematology
Volume 43, Issue 1 , Pages 11-23 , January 2006

Genetics of Risk Factors for Graft-Versus-Host Disease

  • Effie W. Petersdorf

      Affiliations

    • Department of Medicine, University of Washington, Seattle, WA.
    • Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA.
    • Corresponding Author InformationAddress correspondence to Effie W. Petersdorf, MD, Professor of Medicine, University of Washington, Member, Fred Hutchinson Cancer Research Center, Division of Clinical Research, 1100 Fairview Ave North, D4-100, Seattle, WA 98109.
    • ,
  • Mari Malkki

      Affiliations

    • Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA.

References 

  1. Marsh SG  WHO Nomenclature Committee for Factors of the HLA System . Nomenclature for factors of the HLA System, update December 2004 . Hum Immunol . 2005;66:329–330
  2. Mickelson E , Petersdorf EW . Histocompatibility . In:  Blume KG ,  Forman SJ ,  Appelbaum FR editor. Thomas’ Hematopoietic Cell Transplantation . (ed 3). Oxford, UK: Blackwell; 2004;p. 31–42
  3. Cornelissen JJ , Carston M , Kollman C , King R , Dekker AW , Lowenberg B , et al.   Unrelated marrow transplantation for adult patients with poor-risk acute lymphoblastic leukemia (Strong graft-versus-leukemia effect and risk factors determining outcome) . Blood . 2001;97:1572–1577
  4. Morishima Y , Sasazuki T , Inoko H , Juji T , Akaza T , Yamamoto K , et al.   The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B and HLA-Dr matched unrelated donors . Blood . 2002;99:4200–4206
  5. Petersdorf EW , Gooley TA , Anasetti C, Martin PJ , Smith AG , Mickelson E , et al.   Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient . Blood . 1998;92:3515–3520
  6. Sasazuki T , Juji T , Morishima Y, Kinukawa N , Kashiwabara H , Inoko H , et al.   Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor . N Engl J Med . 1998;339:1177–1185
  7. Prezpiorka D , Saliba R , Cleary K , Fischer H , Tonai R , Fritsche H , et al.   Tacrolimus does not abrogate the increased risk of acute graft-versus-host disease after unrelated-donor marrow transplantation with allelic mismatching at HLA-DRB1 and HLA-DQB1 . Biol Blood Marrow Transplant . 2000;6:190–197
  8. Ferrara GB , Bacigalupo A , Lamparelli T, Lanino E , Delfino L , Morabito A , et al.   Bone marrow transplantation from unrelated donors (The impact of mismatches with substitutions at position 116 of the human leukocyte antigen class I heavy chain) . Blood . 2001;98:3150–3155
  9. Keever-Taylor CA , Bredeson C , Loberiza FR , Casper JT , Lawton C , Rizzo D , et al.   Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT (Effect of HLA disparity, ABO incompatibility, and method of T-cell depletion) . Biol Blood Marrow Transplant . 2001;7:620–630
  10. Petersdorf EW , Gooley T , Malkki M , Anasetti C , Martin P , Woolfrey A , et al.   The biological significance of HLA-DP gene variation in haematopoietic cell transplantation . Brit J Haematol . 2001;112:988–994
  11. Petersdorf EW , Kollman C , Hurley CK , Dupont B , Nademanee A , Begovich AB , et al.   Effect of HLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia (The US National Marrow Donor Program Experience) . Blood . 2001;98:2922–2929
  12. Schaffer M , Aldener-Cannavá A , Remberger M , Ringdén O , Olerup O . Roles of HLA-B, HLA-C and HLA-DPA1 incompatibilities in the outcome of unrelated stem-cell transplantation . Tissue Antigens . 2003;2:243–250
  13. Shaw BE , Potter MN , Mayor NP , Pay AL , Smith C , Goldman JM , et al.   The degree of matching at HLA-DPB1 predicts for acute graft-versus-host disease and disease relapse following haematopoietic stem cell transplantation . Bone Marrow Transplant . 2003;31:1001–1008
  14. Caillat-Zucman S , Le Deist F , Haddad E , Gannagé M , Dal Cortivo L , Jabado N , et al.   Impact of HLA matching on outcome of hematopoietic stem cell transplantation in children with inherited diseases (a single-center comparative analysis of genoidentical, haploidentical or unrelated donors) . Bone Marrow Transplant . 2004;33:1089–1095
  15. Flomenberg N , Baxter-Lowe LE , Confer D , Fernandez-Vina M , Filipovich A , Horowitz M , et al.   Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation (HLA-C mismatching is associated with a strong adverse effect on transplantation outcome) . Blood . 2004;104:1923–1930
  16. Gallardo D , Brunet S , Torres A , Alonso-Nieto M , Vallejo C , Jiménez A , et al.   HLA-DPB1 mismatch in HLA-A-B-DRB1 identical sibling donor stem cell transplantation and acute graft-versus-host disease . Transplant . 2004;77:1107–1110
  17. Petersdorf EW , Anasetti C , Martin PJ , Gooley T , Radich J , Malkki M , et al.   Limits of HLA mismatching in unrelated hematopoietic cell transplantation . Blood . 2004;104:2976–2980
  18. Petersdorf EW . Hematopoietic cell transplantation . In:  Blume KG ,  Forman SJ ,  Appelbaum FR editor. Thomas’ Hematopoietic Cell Transplantation . (ed 3). Oxford, UK: Blackwell; 2004;p. 1132–1149
  19. Drobyski WR , Klein J , Flomenberg N , Pietryga D , Vesole DH , Margolis DA , et al.   Superior survival associated with transplantation of matched unrelated versus one-antigen-mismatched unrelated or highly leukocyte antigen-disparate haploidentical family donor marrow grafts for the treatment of hematologic malignancies (Establishing a treatment algorithm for recipients of alternative donor grafts) . Blood . 2002;99:806–814
  20. Kiehl MG , Kraut L , Schwerdtfeger R , Hertenstein B , Remberger M , Kroeger N , et al.   Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia (No difference in related compared with unrelated transplant in first complete remission) . J Clin Oncol . 2004;22:2816–2825
  21. Baker SK , Gurney JG , Ness KK , Bhatia R , Forman SJ , Francisco L , et al.   Late effects in survivors of chronic myeloid leukemia treated with hematopoietic cell transplantation (Results from the Bone Marrow Transplant Survivor Study) . Blood . 2004;104:1898–1906
  22. Stewart BL , Storer B , Storek J , Deeg HJ , Storb R , Hansen JA , et al.   Duration of immunosuppressive treatment for chronic graft-versus-host disease . Blood . 2004;104:3501–3506
  23. Loiseau P , Espérou H , Busson M , Sghiri R , Tamouza R , Hilarius M , et al.   DPB1 disparities contribute to severe GVHD and reduced patient survival after unrelated donor bone marrow transplantation . Bone Marrow Transplant . 2002;30:497–502
  24. Zino E , Frumento G , Marktel S , Sormani MP , Ficara F , Di Terlizzi S , et al.   A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation . Blood . 2004;103:1417–1424
  25. Petersdorf EW, Gooley T, Malkki M, and Horowitz M for the International Histocompatibility Working Group in Hematopoietic Cell Transplantation: Impact of donor-recipient HLA matching on survival after myeloablative hematopoietic cell transplantation from unrelated donors, in Hansen J, Dupont B (eds): HLA 2004: Immunobiology of the Human MHC, Proceedings of the 13th International Histocompatibility Workshop and Conference. Seattle, WA: IHWG Press (in press)
  26. Kaminski E , Hows J , Man S , Brookes P , Mackinnon S , Hughes T , et al.   Prediction of graft versus host disease by frequency analysis of cytotoxic T cells after unrelated donor bone marrow transplantation . Transplantation . 1989;48:608–613
  27. Niederwieser D , Maris M , Shizuru JA , Petersdorf E , Hegenbart U , Sandmaier BM , et al.   Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HSCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases . Blood . 2003;101:1620–1629
  28. Ringdén O , Schaffer M , Le Blanc K , Persson U , Hauzenberger D , Abedi MR , et al.   Which donor should be chosen for hematopoietic stem cell transplantation among unrelated HLA-A, -B, and –DRB1 genomically identical volunteers? . Biol Blood Marrow Transplant . 2004;10:128–134
  29. Dini G , Valsecchi M , Micalizzi C , Micalizzi C , Busca A , Balduzzi A , et al.   Impact of marrow unrelated donor search duration on outcome of children with acute lymphoblastic leukemia in second remission . Bone Marrow Transplant . 2003;32:325–331
  30. Barker JN , Krepski TP , DeFor TE , Davies SM , Wagner JE , Weisdorf DJ , et al.   Searching for unrelated donor hematopoietic stem cells (Availability and speed of umbilical cord blood versus bone marrow) . Biol Blood Marrow Transplant . 2002;8:257–260
  31. Gluckman E , Broxmeyer HA , Auerbach AD , Friedman HS , Douglas GW , Devergie A , et al.   Hematopoietic reconstitution in a patient with Fanconi’s anemia by means of umbilical-cord blood from an HLA-identical sibling . N Engl J Med . 1989;321:1174–1178
  32. Kurtzberg J , Laughlin M , Graham ML , Smith C , Olson JF , Halperin EC , et al.   Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients . N Engl J Med . 1996;335:157–166
  33. Rubinstein P , Carrier C , Scaradavou A , Kurtzberg J , Adamson J , Migliaccio AR , et al.   Outcomes among 562 recipients of placental-blood transplants from unrelated donors . N Engl J Med . 1998;339:1565–1577
  34. Wagner JE , Barker JN , Defor TE , Baker KS , Blazar BR , Eide C , et al.   Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases (Influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival) . Blood . 2002;100:1611–1618
  35. Laughlin MJ , Eapen M , Rubinstein P , Wagner JE , Zhang MJ , Champlin RE , et al.   Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia . N Engl J Med . 2004;351:2265–2275
  36. Rocha V , Labopin M , Sanz G , Arcese W , Schwerdtfeger R , Bosi A , et al.   Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia . N Engl J Med . 2004;351:2276–2285
  37. Gluckman E , Rocha V , Arcese W , Michel G , Sanz G , Chan KW , et al.   Factors associated with outcomes of unrelated cord blood transplant (Guidelines for donor choice) . Exp Hematol . 2004;32:397–407
  38. Rubinstein P , Stevens CE . Placental blood for bone marrow replacement (The New York Blood Center’s program and clinical results) . Baillieres Best Pract Res Clin Haematol . 2000;13:565–584
  39. Parham P . MHC class I molecules and KIRs in human history, health and survival . Nat Rev Immunol . 2005;5:201–214
  40. Marsh SG , Parham P , Geraghty DE , Trowsdale J , Middleton D , Vilches C , et al.   Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002 . Immunogenetics . 2003;55:220–226
  41. Hsu KC , Dupont B . Natural killer cell receptors (Regulating innate immune responses to hematologic malignancy) . Semin Hematol . 2005;42:91–103
  42. Trowsdale J , Barten R , Haude A , Steward C , Beck S , Wilson M , et al.   The genomic context of natural killer receptor extended gene families . Immunol Rev . 2001;181:20–38
  43. Ruggeri L , Capanni M , Urbani E , Perruccio K , Shlomchik WD , Tosti A , et al.   Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants . Science . 2002;295:2097–2100
  44. Aversa F , Tabilio A , Velardi A , Cunningham I , Terenzi A , Falzetti F , et al.   Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype . N Engl J Med . 1998;339:1186–1193
  45. Ruggeri L , Capanni M , Casucci M , Volpi I , Tosti A , Perruccio K , et al.   Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation . Blood . 1999;94:333–339
  46. Beelen D , Ottinger H , Ferencik S , Elmaagacli A , Peceny R , Trenschel R , et al.   Genotypic inhibitory killer immunoglobulin-like receptor ligand incompatibility enhances the long-term antileukemic effect of unmodified allogeneic hematopoietic stem cell transplantation in patients with myeloid leukemias . Blood . 2004;105:2594–2600
  47. Giebel S , Locatelli F , Lamparelli T , Velardi A , Davies S , Frumento G , et al.   Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors . Blood . 2003;102:814–818
  48. Davies SM , Ruggeri L , DeFor T , Wagner JE , Weisdorf DJ , Miller JS , et al.   Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Killer immunoglobulin-like receptor . Blood . 2002;100:3825–3827
  49. Bornhauser M , Schwerdtfeger R , Martin H , Frank KH , Theuser C , Ehninger G , et al.   Role of KIR ligand incompatibility in hematopoietic stem cell transplantation using unrelated donors . Blood . 2004;103:2860–2861
  50. Bishara A , De Santis D , Witt CC , Brautbar C , Christiansen FT , Or R , et al.   The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD . Tissue Antigens . 2004;63:204–211
  51. Farag S , Bacigalupo A , Dupont B , Caligiuri M , Nelson G , Miller J , et al.   The effect of killer immunoglobulin-like receptor KIR ligand incompatibility on outcome of unrelated donor bone marrow transplantation UDT . Blood . 2004;104:434
  52. Leung W , Iyengar R , Turner V , Lang P , Bader P , Conn P , et al.   Determinants of antileukemia effects of allogeneic NK cells . J Immunol . 2004;172:644–650
  53. Hsu K , Keever-Taylor C , Wilton A , Pinto C , Heller G , Arkun K , et al.   Improved outcome in allogeneic hematopoietic stem cell transplantation in acute myelogenous leukemia (AML) predicted by donor KIR genotype and recipient HLA genotype in T-cell depleted HLA-identical sibling transplants . Blood . 2005;105:4878–4884
  54. Hsu KC , Malkki M , Gooley TA , et al.   Missing killer immunoglobulin-like receptor (KIR) ligand confers protection from relapse in recipients of unrelated hematopoietic cell transplantation (HSCT) for AML . 2005; Tandem ASBMT/CIBMTR Meetings, Keystone, CO, February 10-14, (abstr)
  55. Ferrara JL . The cytokine modulation of acute graft-versus-host disease . Bone Marrow Transplant . 1998;21(suppl 3):S13–S15
  56. Cavet J , Dickinson AM , Norden J , Taylor PR , Jackson GH , Middleton PG , et al.   Interferon-gamma and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation . Blood . 2001;98:1594–1600
  57. Hattori H , Matsuzaki A , Suminoe A , Ihara K , Nagatoshi Y , Sakata N , et al.   Polymorphisms of transforming growth factor-beta1 and transforming growth factor-beta1 type II receptor genes are associated with acute graft-versus-host disease in children with HLA-matched sibling bone marrow transplantation . Bone Marrow Transplant . 2002;30:665–671
  58. Socie G , Loiseau P , Tamouza R , Janin A , Busson M , Gluckman E , et al.   Both genetic and clinical factors predict the development of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation . Transplantation . 2001;72:699–706
  59. Cullup H , Dickinson AM , Cavet J , Jackson GH , Middleton PG . Polymorphisms of interleukin-1alpha constitute independent risk factors for chronic graft-versus-host disease after allogeneic bone marrow transplantation . Br J Haematol . 2003;122:778–787
  60. MacMillan ML , Radloff GA , Defor TE , Weisdorf DJ , Davies SM . Interleukin-1 genotype and outcome of unrelated donor bone marrow transplantation . Br J Haematol . 2003;121:597–604
  61. Lin MT , Storer B , Martin PJ , Tseng LH , Gooley T , Chen PJ , et al.   Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation . N Engl J Med . 2003;349:2201–2210
  62. Cullup H , Dickinson AM , Jackson GH , Taylor PR , Cavet J , Middleton PG . Donor interleukin 1 receptor antagonist genotype associated with acute graft-versus-host disease in human leucocyte antigen-matched sibling allogeneic transplants . Br J Haematol . 2001;113:807–813
  63. Mullighan C , Heatley S , Doherty K , Szabo F , Grigg A , Hughes T , et al.   HLA immunogenetic polymorphisms and the risk of complications after allogeneic hemopoietic stem-cell transplantation . Transplantation . 2004;77:587–596
  64. Rocha V , Franco RF , Porcher R , Bittencourt H , Silva WA , Latouche A , et al.   Host defense and inflammatory gene polymorphisms are associated with outcomes after HLA-identical sibling bone marrow transplantation . Blood . 2002;100:3908–3918
  65. Stark GL , Dickinson AM , Jackson GH , Taylor PR , Proctor SJ , Middleton PG . Tumour necrosis factor receptor type II 196M/R genotype correlates with circulating soluble receptor levels in normal subjects and with graft-versus-host disease after sibling allogeneic bone marrow transplantation . Transplantation . 2003;76:1742–1749
  66. MacMillan ML , Radloff GA , Kiffmeyer WR, DeFor TE , Weisdorf DJ , Davies SM . High-producer interleukin-2 genotype increases risk for acute graft-versus-host disease after unrelated donor bone marrow transplantation . Transplantation . 2003;76:1758–1762
  67. Cavet J , Middleton PG , Segall M , Noreen H , Davies SM , Dickinson AM . Recipient tumor necrosis factor-alpha and interleukin-10 gene polymorphisms associate with early mortality and acute graft-versus-host disease severity in HLA-matched sibling bone marrow transplants . Blood . 1999;94:3941–3946
  68. Keen LJ , Defor TE , Bidwell JL , Davies SM , Bradley BA , Hows JM . Interleukin-10 and tumor necrosis factor alpha region haplotypes predict transplant-related mortality after unrelated donor stem cell transplantation . Blood . 2004;103:3599–3602
  69. Takahashi H , Furukawa T , Hashimoto S , Suzuki N , Kuroha T , Yamazaki F , et al.   Contribution of TNF-alpha and IL-10 gene polymorphisms to graft-versus-host disease following allo-hematopoietic stem cell transplantation . Bone Marrow Transplant . 2000;26:1317–1323
  70. Middleton PG , Taylor PR , Jackson G , Proctor SJ , Dickinson AM . Cytokine gene polymorphisms associating with severe acute graft-versus-host disease in HLA-identical sibling transplants . Blood . 1998;92:3943–3948
  71. Kogler G , Middleton PG , Wilke M , Rocha V , Esendam B , Enczmann J , et al.   Recipient cytokine genotypes for TNF-alpha and IL-10 and the minor histocompatibility antigens HY and CD31 codon 125 are not associated with occurrence or severity of acute GVHD in unrelated cord blood transplantation (A retrospective analysis) . Transplantation . 2002;74:1167–1175
  72. Cardoso SM , Defor TE , Tilley LA , Bidwell JL , Weisdorf DJ , MacMillan ML . Patient interleukin-18 GCG haplotype associates with improved survival and decreased transplant-related mortality after unrelated-donor bone marrow transplantation . Br J Haematol . 2004;126:704–710
  73. Ishikawa Y , Kashiwase K , Akaza T , Morishima Y , Inoko H , Sasazuki T , et al.   Polymorphisms in TNFA and TNFR2 affect outcome of unrelated bone marrow transplantation . Bone Marrow Transplant . 2002;29:569–575
  74. Delaney NL , Esquenazi V , Lucas DP , Zachary AA , Leffell MS . TNF-alpha, TGF-beta, IL-10, IL-6, and IFN-gamma alleles among African Americans and Cuban Americans. Report of the ASHI Minority Workshops: Part IV . Hum Immunol . 2004;65:1413–1419
  75. Meenagh A , Williams F , Ross OA , Patterson C , Gorodezky C , Hammond M . Frequency of cytokine polymorphisms in populations from western Europe, Africa, Asia, the Middle East and South America . Hum Immunol . 2002;63:1055–1061
  76. Udalova IA , Nedospasov SA , Webb GC , Chaplin DD , Turetskaya RL . Highly informative typing of the human TNF locus using six adjacent polymorphic markers . Genomics . 1993;16:180–186
  77. Wilson AG , de Vries N , Pociot F , di Giovine FS , van der Putte LB , Duff GW . An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles . J Exp Med . 1993;177:557–560
  78. Schots R , Kaufman L , Van Riet I , Ben Othman T , De Waele M , Van Camp B , et al.   Proinflammatory cytokines and their role in the development of major transplant-related complications in the early phase after allogeneic bone marrow transplantation . Leukemia . 2003;17:1150–1156
  79. Turner DM , Williams DM , Sankaran D , Lazarus M , Sinnott PJ , Hutchinson IV . An investigation of polymorphism in the interleukin-10 gene promoter . Eur J Immunogenet . 1997;24:1–8
  80. Takatsuka H , Takemoto Y , Okamoto T , Fujimori Y , Tamura S , Wada H , et al.   Predicting the severity of graft-versus-host disease from interleukin-10 levels after bone marrow transplantation . Bone Marrow Transplant . 1999;24:1005–1007
  81. Holler E , Roncarolo MG , Hintermeier-Knabe R , Eissner G , Ertl B , Schulz U , et al.   Prognostic significance of increased IL-10 production in patients prior to allogeneic bone marrow transplantation . Bone Marrow Transplant . 2000;25:237–241
  82. Miura Y , Thoburn CJ , Bright EC , Chen W , Nakao S , Hess AD . Cytokine and chemokine profiles in autologous graft-versus-host disease GVHD (interleukin 10 and interferon gamma may be critical mediators for the development of autologous GVHD) . Blood . 2002;100:2650–2658

 E.W.P. is supported by Grants No. CA18029, CA100019, CA15704, AI33484, and AI49213 from the National Institutes of Health (NIH). M.M. is supported by CA18029, AI33484, and AI49213 from the NIH and by the Amy Strelzer Manasevit Scholars Program from the National Marrow Donor Program (NMDP).

PII: S0037-1963(05)00167-8

doi: 10.1053/j.seminhematol.2005.09.002

Seminars in Hematology
Volume 43, Issue 1 , Pages 11-23 , January 2006

Article Tools